About 5,240,000 results
Open links in new tab
FDA approves new treatment for adults with serious rare blood …
Europe's CHMP turns down Apellis' pegcetacoplan appeal, …
Sobi and Apellis announce positive topline results from phase 3 …
Apellis plans FDA filing after drug success in kidney trial
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal …
FDA Approves SYFOVRE™ (pegcetacoplan injection) as the First …
Apellis Announces FDA Acceptance and Priority Review of the
Positive data from phase 2 NOBLE study of pegcetacoplan …
SYFOVRE® (pegcetacoplan injection) Continued to Demonstrate …
Long-Term Safety and Efficacy of Pegcetacoplan Treatment in …
- Some results have been removed